variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele
APOE-C130R,APOE,"This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).",High,Well-established,Pathogenic,0.14,Mental and behavioral;Nervous system,Complex/Other,Heterozygous,9343467;11950276;15123497;17428983,rs429358,4,chr19,45411941,C
FGD1-P312L,FGD1,"Extremely rare variant, reported to cause X-linked mental retardation. Only one case observed -- not enough information to establish statistical significance (it is also possible this was an unusual coincidental finding). Other mutations in this gene cause Aarskog-Scott syndrome, however the family reported did not have features of this syndrome.",High,Uncertain,Pathogenic,0.00046,Other,Recessive,Heterozygous,11940089,,5,chrX,54496615,A
MSR1-R293X,MSR1,"Associated with increased risk of Barrett's esophagus and/or esophageal cancer. Our very rough estimate is that the increased risk may be around 4x (25% risk of Barrett's esophagus, assuming population average is 5%, and 1.2% lifetime risk of esophageal cancer compared to average .4% risk).",Low,Likely,Pathogenic,0.0074,Cancer,Dominant,Heterozygous,12244320;12958598;21791690,rs41341748,2,chr8,16012594,A
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Homozygous,11062481;15235023,rs144848,2,chr13,32906729,C
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Homozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,
HFE-S65C,HFE,"A ""mild"" variant which may cause a very small increased risk of iron overload (hereditary hemachromatosis).",Low,Uncertain,Pathogenic,0.0098,Blood,Recessive,Heterozygous,12377814;18036208,,0,chr6,26091185,T
ERCC6-R1213G,ERCC6,"When homozygous, this variant may cause Cockayne Syndrome, which is a severe autosomal-recessive disorder characterized by abnormal early growth and development, abnormal sensitivity to sunlight, and premature aging. Cockayne Syndrome Type I and Type II lead to death in early childhood. Several other variants in the ERCC6 gene are linked to Cockayne Syndrome. This variant may also be linked to age-related macular degeneration like other ERCC6 variants, and has been linked to colorectal cancer in one study. ",Low,Uncertain,Pathogenic,0.2,Anatomical and congenital;Cancer;Hearing and vision,Recessive,Heterozygous,,rs2228527,0,chr10,50678369,C
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C
DPYD-M166V,DPYD,Associated with DPYD deficiency and poor prognosis for chemotherapy w/ 5-flurorouracil. ,High,Likely,Pharmacogenetic,0.078,Other,Unknown,Heterozygous,11895907;14635116;19104657,rs2297595,5,chr1,98165091,C
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Homozygous,,rs1544410,0,,,
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Homozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A
PCSK9-R46L,PCSK9,This variant is reported to have a dominant protective effect against coronary heart disease. Carriers of this variant have about half the risk of coronary heart disease compared to non-carriers (6.3% risk in carriers vs. 11.8% risk in non-carriers).,Moderate,Likely,Protective,0.01,Heart and circulatory,Unknown,Heterozygous,16554528,rs11591147,3,chr1,55505647,T
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Homozygous,18236005;19081515,rs1799990,0,chr20,4680251,G
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Homozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Heterozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Homozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T
PKD1-A4059V,PKD1,Probably benign.,Low,Likely,Benign,0.057,Other,Unknown,Heterozygous,19686598,rs3209986,,chr16,2140554,A
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Heterozygous,,rs12742169,,chr1,201052310,T
EDAR-V370A,EDAR,"Associated with thicker hair, common in Chinese and Japanese individuals and thought to be Asian-specific.",Low,Uncertain,Benign,0.011,Other,Unknown,Heterozygous,18065779;18561327;18704500;19804850,rs3827760,,chr2,109513601,G
GJB2-V27I,GJB2,"Probable non-pathogenic; other variants in gene associated with hearing loss.
A few controversial mutations of uncertain or evolving clinical signiÔ¨Åcance are included in this prototype.
Examples include V27I, M34T, V37I, and E114G in the GJB2 gene and IVS2-2AG in the SLC26A5 gene.
This variant is also observed both in Case and Control in the study of hearing loss.",Low,Uncertain,Benign,0.0027,Hearing and vision,Unknown,Heterozygous,11494963;15790391;19719946,rs2274084,,chr13,20763642,T
PCCA-I475V,PCCA,"Reported as a polymorphism, tentatively presumed benign.",Low,Uncertain,Benign,0.038,Other,Unknown,Heterozygous,10101253,rs35719359,,chr13,100962156,G
GJB3-R32W,GJB3,"Probably benign. Although Polyphen 2 predicts it be damaging and some publications suggested it might have a functional effect, others report it to be a fairly common polymorphism and functional studies failed to find a difference between it and wild type.",Low,Uncertain,Benign,0.022,Other,Unknown,Heterozygous,10888284;11175305;12702148,rs1805063,,chr1,35250457,T
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C
MAPT-R370W,MAPT,Probably benign.,Low,Uncertain,Benign,0.16,Other,Unknown,Heterozygous,15365985,rs17651549,,chr17,44061278,T
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T
PTCH1-P1315L,PTCH1,"Common polymorphism, presumed benign.",Low,Uncertain,Benign,0.3,Other,Unknown,Homozygous,15712338,rs357564,,chr9,98209594,A
XPC-L16V,XPC,Reported as a nonpathogenic polymorphism.,Low,Uncertain,Benign,0.0047,Other,Unknown,Heterozygous,18544627,rs1870134,,chr3,14220023,C
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C
